The AltoStar® PCR Kits 1.5 are developed for the simultaneous testing of pathogens by harmonized cycling conditions and enabling the identification of clinical pathogen using the AltoStar®Molecular Diagnostic Workflow. The AltoStar® CMV PCR Kit 1.5 is part of the pathogen panel for testing immunocompromised patients.
Product not licensed with Health Canada and not FDA cleared or approved. Kit not available in all countries.
Detection and quantification of cytomegalovirus (CMV) specific DNA
Ready-to-use kit including Quantification Standards
Quantification Standards calibrated against the 1st WHO International Standard for Human cytomegalovirus for nucleic acid amplification techniques (NAT) (NIBSC code: 09/162)
Analytical sensitivity reported in IU/ml
Mixed batches possible: all sample types in parallel
Simultaneous processing: up to 8 assays in the same run
CE-IVD marked in vitro diagnostic test
The AltoStar® CMV PCR Kit 1.5 is an in vitro diagnostic test, based on real-time PCR technology, for the detection and quantification of human cytomegalovirus (CMV) specific DNA in human plasma, whole blood and urine. The AltoStar® CMV PCR Kit 1.5 is configured for use with the CFX96™ Deep Well Dx System (Bio-Rad) in combination with the AltoStar® Automation System AM16, the AltoStar® Purification Kit 1.5 and the AltoStar® Internal Control 1.5.
AltoStar® CMV PCR Kit 1.5
Human EDTA plasma
Human citrate plasma
Human EDTA whole blood
Human citrate whole blood
For use with
AltoStar® Automation System AM16 / AltoStar® Connect software
AltoStar® Purification Kit 1.5
AltoStar® Internal Control 1.5
CFX96™ Deep Well Dx System
The results generated with the AltoStar® CMV PCR Kit 1.5 have to be interpreted in conjunction with other clinical and laboratory findings. The AltoStar® CMV PCR Kit 1.5 is intended for use by professional users trained in molecular biological techniques.